Viral Hepatitis and Liver Cancer in Korea: an Epidemiological Perspective

Yeo, Yohwan; Gwack, Jin; Kang, Seokin; Koo, Boyeon; Jung, Sun Jae; Dhamala, Prakash; Ko, Kwang-Pil; Lim, Young-Khi; Yoo, Keun-Young

추천

검색

자료유형: 학술저널

저자정보: Yeo, Yohwan (Department of Preventive Medicine, Seoul National University College of Medicine) Gwack, Jin (Division of Epidemic Intelligence Service, Korea Centers for Disease Control and Prevention) Kang, Seokin (Soonchunhyang University College of Medicine) Koo, Boyeon (Seoul National University College of Nursing) Jung, Sun Jae (Department of Preventive Medicine, Seoul National University College of Medicine) Dhamala, Prakash (Department of Preventive Medicine, Seoul National University College of Medicine) Ko, Kwang-Pil (Department of Preventive Medicine, Gachon University of Medicine and Science) Lim, Young-Khi (Department of Radiological Science, Gachon University College of Health Science) Yoo, Keun-Young (Department of Preventive Medicine, Seoul National University College of Medicine)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제11호

발행연도: 2013.1

수록면: 6,227 - 6,231 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

In the past, hepatitis B virus (HBV) infection was endemic in the general Korean population. The association of HBV infection with the occurrence of liver cancer has been well demonstrated in several epidemiologic studies. While the mortality rates of liver cancer in Korea have decreased steadily over the last decade, the presence of hepatitis B surface antigen (HBsAg) in mothers remains high at 3-4%, and 25.5% of these HBsAg positive mothers are positive for hepatitis B e antigen (HBeAg). HBV infection caused almost a quarter of hepatocellular carcinoma (HCC) cases and one-third of deaths from HCC. These aspects of HBV infection prompted the Korean government to create a vaccination program against HBV in the early 1980s. In 1995, the Communicable Disease Prevention Act (CDPA) was reformed, and the government increased the number of HBV vaccines in the National Immunization Program (NIP), driving the vaccination rate up to 95%. In 2000, the National Health Insurance Act (NHIA) was enacted, which provided increased resources for the prevention of perinatal HBV infection. Then in 2002, the Korean government, in conjunction with the Korean Medical Association (KMA), launched an HBV perinatal transmission prevention program. The prevalence of HBsAg in children had been high (4-5%) in the early 1980s, but had dropped to below 1% in 1995, and finally reached 0.2% in 2006 after the NIP had been implemented. After the success of the NIP, Korea finally obtained its first certification of achievement from the Western Pacific Regional Office of the World Health Organization (WPRO-WHO) for reaching its goal for HBV control. An age-period-cohort analysis showed a significant reduction in the liver cancer mortality rate in children and adolescents after the NIP had been implemented. In addition to its vaccination efforts, Korea launched the National Cancer Screening Program (NCSP) for 5 leading sites of cancer, including the liver, in 1999. As a consequence of this program, the 5-year liver cancer survival rate increased from 13.2% (1996-2000) to 23.3% (2003-2008). The development of both the primary and secondary prevention for liver cancer including HBV immunization and cancer screening has been of critical importance.

#Hepatitis B #vaccination #screening #liver cancer

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요